Selected publications:

 

 Abdollahi A, Lipson KE, Sckell A, Zieher H, Klenke F, Poerschke D, Roth A, Han X, Krix M, Bischof M, Hahnfeldt P, Grone HJ, Debus J, Hlatky L, Huber PE.
Combined Therapy with Direct and Indirect Angiogenesis Inhibitors results in Enhanced Anti-Angiogenic and Anti-Tumor Effects.
Cancer Research, 2003; 63: 8890-8898.
  Abdollahi A, Lipson KE, Han X, Krempien R, Trinh T, Weber KJ, Hahnfeldt P, Hlatky L, Debus J, Howlett AR, Huber PE.
SU5416 and SU6668 decrease angiogenic effects of radiation-induced factor productions by tumor cells and amplify the direct anti-endothelial action of radiation in vitro.
Cancer Research, 2003; 63: 3755-3763.
  Abdollahi A, Hahnfeldt P, Maercker C, Grone HJ, Debus J, Ansorge W, Folkman J, Hlatky L, and Huber PE.
Endostatin's antiangiogenic signaling network.
Mol Cell, 2004; 13: 649-663.

comments in:
a) Robert Benezra and Shahin Rafii.
Endostatin's endpoints-deciphering the endostatin antiangiogenic pathway.
Cancer Cell, 2004; 3,205-206.
b) Editors Choice.
An antiangiogenic network.
Science, 2004; 303: 1949.
c) Science's STKE Signal Transduktion knowledge environment
Angiogenesis: Endostatin's signaling network
Science STKE, 2004; 224: 93.

  Abdollahi, A., Domhan, S., Jenne, J. W., Hallaj, M., Dell'Aqua, G., Mueckenthaler, M., Richter, A., Martin, H., Debus, J., Ansorge, W., Hynynen, K., and Huber, P. E.
Apoptosis signals in lymphoblasts induced by focused ultrasound.
FASEB J., 2004; 18: 1413-1414.
  Abdollahi A, Griggs DW, Zieher H, Roth A, Lipson KE, Saffrich R, Grone HJ, Hallahan DE, Reisfeld RA, Debus J, Niethammer AG, Huber PE.
Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy.
Clin Cancer Res. 2005; 11: 6270-9.
  Abdollahi A, Hlatky L, Huber PE.
Endostatin: The Logic of Antiangiogenic Therapy
Drug Resistance Updates, 2005; 8:59-74.
  Abdollahi A, Li M, Ping G, Plathow C, Domhan S, Kiessling F, Lee LB, McMahon G, Groene HJ, Lipson KE, Huber PE.
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
Journal of Experimental Medicine, 2005; 201:925-35.
  Huber PE, Bischof M, Heiland S, Peschke P, Stoffregen C, Grone HJ, Debus J, Lipson K, Abdollahi A.
Trimodal Cancer Treatment: Beneficial Effects of Combined Antiangiogenesis, Radiation and Chemotherapy
Cancer Research, 2005; 65:3643-55.
Amir Abdollahi, Christian Schwager, Jorg Kleef, Irene Esposito, Sophie Domhan, Peter Peschke, Kai Hauser, Philip Hahnfeldt, Lynn Hlatky, Juergen Debus, Jeffrey M. Peters, Helmut Friess, Judah M. Folkmann und Peter E. Huber
Transcriptional network governing the angiogenetic switch in human pancreatic cancer.
Proceedings of the National Academie of Science 2007, DOI: 10.1073/pnas.0705505104
Domhan S, Muschal S, Schwager C, Morath C, Wirkner U, Ansorge W, Maercker C, Zeier M, Huber PE, Abdollahi A.
Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid.
Mol Cancer Ther. 2008 Jun;7(6):1656-68.
Almog N, Ma L, Raychowdhury R, Schwager C, Erber R, Short S, Hlatky L, Vajkoczy P, Huber PE, Folkman J, Abdollahi A.
Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic Phenotype
Cancer Research. 2009 69:836-844
Lee TY, Muschal S, Pravda EA, Folkman J, Abdollahi A, Javaherian K.
Angiostatin regulates the expression of antiangiogenic and proapoptotic
Blood.27 August 2009, Vol. 114, No. 9, pp. 1987-1998.

       Comments in
     Mowery YM, Pizzo SV.
     The antitumorigenic trifecta
      2009 Aug 27;114(9):1727-8.
Abdollahi A, Folkman J.
Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
Drug Resist Updat. 2010 Jan 8. [Epub ahead of print]
   

NCBI link for complete list of publications